| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 144, 787-795, Copyright © 1994 by American Society for Investigative Pathology
REGULAR ARTICLES |
M Liebert, R Washington, G Wedemeyer, TE Carey and HB Grossman
Section of Urology, University of Michigan, Ann Arbor 48109.
In normal epithelial cells, the alpha 6 beta 4 integrin co-localizes with the hemidesmosomal anchoring complex on the basolateral surface of basal cells. We studied the co-expression of alpha 6 beta 4 integrin with collagen VII, a component of the hemidesmosomal anchoring complex, in normal bladder tissues and in bladder cancers. In normal bladder, the alpha 6 beta 4 integrin co-localized with collagen VII at the junction of the basolateral surface of the basal urothelial cells and the lamina propria. In five of six noninvasive bladder cancers, the localization of collagen VII remained unchanged, found at the junction of the basal cells and the papillary connective tissue. However, in these tumors the alpha 6 beta 4 expression was not polarized and was expressed on suprabasal as well as basal cells. In invasive bladder cancers, the majority (25 of 30) showed either loss of alpha 6 beta 4 and/or collagen VII expression or showed a lack of co-localization of alpha 6 beta 4 and collagen VII. Our results show derangement of the co- localization of these two components of the hemidesmosomal anchoring complex is a consistent event in bladder cancer. Furthermore, the degree of derangement increases in invasive cancers. Loss of co- expression and co-localization of alpha 6 beta 4 and collagen VII may predispose cancer cells to local invasion and may facilitate metastasis as well.
This article has been cited by other articles:
 |
|
 |
|
  S.-M. Lee, E.-J. Lee, H.-Y. Hong, M.-K. Kwon, T.-H. Kwon, J.-Y. Choi, R.-W. Park, T.-G. Kwon, E.-S. Yoo, G.-S. Yoon, et al. Targeting Bladder Tumor Cells In vivo and in the Urine with a Peptide Identified by Phage Display Mol. Cancer Res., January 1, 2007; 5(1): 11 - 19. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Koivunen, V. Aaltonen, S. Koskela, P. Lehenkari, M. Laato, and J. Peltonen Protein Kinase C {alpha}/{beta} Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells Cancer Res., August 15, 2004; 64(16): 5693 - 5701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Smith, W. J. Kennedy, P. Harnden, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate Identification of Genes Involved in Human Urothelial Cell-Matrix Interactions: Implications for the Progression Pathways of Malignant Urothelium Cancer Res., February 1, 2001; 61(4): 1678 - 1685. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Ohene-Abuakwa and M. Pignatelli Adhesion Molecules as Diagnostic Tools in Tumor Pathology International Journal of Surgical Pathology, July 1, 2000; 8(3): 191 - 200. [Abstract] [PDF]
|
|
|
|
 |
|
 C. Catusse, M. Polette, C. Coraux, H. Burlet, and P. Birembaut Modified Basement Membrane Composition During Bronchopulmonary Tumor Progression J. Histochem. Cytochem., May 1, 2000; 48(5): 663 - 670. [Abstract] [Full Text]
|
|
|
|
 |
|
 V. Toma, D. Hauri, U. Schmid, D. Ackermann, R. Maurer, G. Alund, H. Knonagel, M. Rist, T. C. Gasser, G. Sauter, et al. Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder Carcinoma Am. J. Pathol., November 1, 1999; 155(5): 1427 - 1432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Takaoka, T. Yamada, M. Gotoh, Y. Kanai, K. Imai, and S. Hirohashi Cloning and Characterization of the Human beta 4-Integrin Gene Promoter and Enhancers J. Biol. Chem., December 11, 1998; 273(50): 33848 - 33855. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
